Glycoprotein YKL-40 Is Elevated and Predicts Disease Severity in Puumala Hantavirus Infection.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
21 08 2019
Historique:
received: 03 07 2019
revised: 15 08 2019
accepted: 17 08 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 10 9 2020
Statut: epublish

Résumé

Most cases of hemorrhagic fever with renal syndrome (HFRS) in Europe are caused by the Puumala hantavirus (PUUV). Typical features of the disease are increased vascular permeability, acute kidney injury (AKI), and thrombocytopenia. YKL-40 is an inflammatory glycoprotein involved in various forms of acute and chronic inflammation. In the present study, we examined plasma YKL-40 levels and the associations of YKL-40 with disease severity in acute PUUV infection. A total of 79 patients treated in Tampere University Hospital during 2005-2014 were studied. Plasma YKL-40 was measured in the acute phase, the recovery phase, and one year after hospitalization. Plasma YKL-40 levels were higher during the acute phase compared to the recovery phase and one year after hospitalization (median YKL-40 142 ng/mL, range 11-3320, vs. 45 ng/mL, range 15-529, vs. 32 ng/mL, range 3-213,

Identifiants

pubmed: 31438470
pii: v11090767
doi: 10.3390/v11090767
pmc: PMC6784349
pii:
doi:

Substances chimiques

Autoantigens 0
Biomarkers 0
CHI3L1 protein, human 0
Chitinase-3-Like Protein 1 0
Interleukin-6 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cytokine. 2013 Apr;62(1):75-80
pubmed: 23490418
Ann Clin Res. 1971;3:1-54
pubmed: 5149038
Nephron. 2017;136(3):193-201
pubmed: 28319945
J Med Virol. 1995 Aug;46(4):293-303
pubmed: 7595404
Infect Dis (Lond). 2016 Sep;48(9):682-7
pubmed: 27299174
J Infect. 2014 Nov;69(5):462-9
pubmed: 24995849
Infect Dis (Lond). 2017 May;49(5):321-332
pubmed: 28049381
J Neuroinflammation. 2019 Jan 24;16(1):16
pubmed: 30678707
J Clin Microbiol. 1996 Jan;34(1):119-25
pubmed: 8748286
Emerg Infect Dis. 2010 Oct;16(10):1584-6
pubmed: 20875284
Thromb Res. 2012 May;129(5):611-5
pubmed: 22133274
Mediators Inflamm. 2014;2014:215140
pubmed: 25132728
Euro Surveill. 2008 Jul 10;13(28):null
pubmed: 18761927
Kidney Int Rep. 2019 May 31;4(9):1296-1303
pubmed: 31517148
Int J Mol Sci. 2013 Nov 19;14(11):22817-25
pubmed: 24256818
Rev Infect Dis. 1989 Nov-Dec;11(6):921-7
pubmed: 2574903
Nephron. 2015;130(3):182-90
pubmed: 26139246
Nephron. 2016;134(2):89-94
pubmed: 27388481
PLoS One. 2018 Dec 5;13(12):e0208017
pubmed: 30517161
Biomarkers. 2018 May - Jun;23(4):357-363
pubmed: 29357700
Immunobiology. 2013 Oct;218(10):1227-34
pubmed: 23706599
BMC Infect Dis. 2010 May 25;10:132
pubmed: 20500875
Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):957-63
pubmed: 21901638
J Am Soc Nephrol. 2017 Feb;28(2):661-670
pubmed: 27451287
Lancet Infect Dis. 2003 Oct;3(10):653-61
pubmed: 14522264
Allergy. 2019 Apr;74(4):685-697
pubmed: 30402955
Cardiovasc Diabetol. 2009 Nov 23;8:61
pubmed: 19930630
PLoS One. 2013 Aug 21;8(8):e71335
pubmed: 23990945
Infect Dis (Lond). 2017 Nov - Dec;49(11-12):840-846
pubmed: 28762841
AIDS. 2017 Jan 14;31(2):247-252
pubmed: 27819802
Kidney Int. 1996 Jan;49(1):217-21
pubmed: 8770970
PLoS One. 2017 Aug 25;12(8):e0183294
pubmed: 28841649
Infection. 2018 Jun;46(3):385-393
pubmed: 29600444
Am J Kidney Dis. 2004 May;43(5):809-16
pubmed: 15112171
J Med Virol. 2011 Apr;83(4):731-7
pubmed: 21328391
Lancet. 1991 Nov 30;338(8779):1353-6
pubmed: 1682736
Scand J Urol. 2017 Oct;51(5):367-372
pubmed: 28644702
Rev Med Virol. 2013 Jan;23(1):35-49
pubmed: 22761056
Mediators Inflamm. 2017;2017:1797512
pubmed: 28588347
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2466-2468.e3
pubmed: 30954645
Nephrol Dial Transplant. 2010 Sep;25(9):2997-3003
pubmed: 20223893
Scand J Infect Dis. 2002;34(5):323-6
pubmed: 12069012
J Infect Dis. 2002 Sep 15;186(6):843-6
pubmed: 12198621
PLoS One. 2012;7(4):e35402
pubmed: 22523590
Indian J Med Microbiol. 2015 Feb;33 Suppl:61-6
pubmed: 25657159
Nat Rev Microbiol. 2013 Aug;11(8):539-50
pubmed: 24020072
Antiviral Res. 2013 Dec;100(3):589-604
pubmed: 24126075
BMC Infect Dis. 2015 Oct 27;15:464
pubmed: 26503619
BMC Nephrol. 2014 Aug 15;15:133
pubmed: 25128003
Liver Transpl. 2008 Sep;14(9):1294-302
pubmed: 18756457
Clin Chim Acta. 2014 Apr 20;431:118-24
pubmed: 24525211
Nephrol Dial Transplant. 2015 Oct;30(10):1693-8
pubmed: 26150428
PLoS One. 2014 Oct 21;9(10):e110481
pubmed: 25333960
Immunobiology. 2018 Nov;223(11):718-727
pubmed: 30077474
Epidemiol Infect. 2010 Oct;138(10):1484-92
pubmed: 20109263
Scand J Gastroenterol. 2003 Jun;38(6):659-65
pubmed: 12825876
Ann Med. 2012 Aug;44(5):468-75
pubmed: 21495786
Am J Kidney Dis. 2017 Aug;70(2):252-261
pubmed: 28363731
Scand J Infect Dis. 1994;26(1):7-13
pubmed: 7910705

Auteurs

Tuula K Outinen (TK)

Department of Internal Medicine, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland. tuula.outinen@gmail.com.
Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland. tuula.outinen@gmail.com.

Paula Mantula (P)

Department of Internal Medicine, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland.
Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.

Pia Jaatinen (P)

Department of Internal Medicine, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland.
Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.
Division of Internal Medicine, Seinäjoki Central Hospital, 60220 Seinäjoki, Finland.

Mari Hämäläinen (M)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33100 & FI-33521 Tampere, Finland.

Eeva Moilanen (E)

The Immunopharmacology Research Group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, 33100 & FI-33521 Tampere, Finland.

Antti Vaheri (A)

Department of Virology, Medicum, University of Helsinki, 00100 Helsinki, Finland.

Heini Huhtala (H)

Faculty of Social Sciences, Tampere University, 33100 Tampere, Finland.

Satu Mäkelä (S)

Department of Internal Medicine, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland.
Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.

Jukka Mustonen (J)

Department of Internal Medicine, Tampere University Hospital, P.O. Box 2000, FI-33521 Tampere, Finland.
Faculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH